MUC1 and COVID-19: A major issue sometimes observed in patients with COVID-19 is that the cause of lung function worsening is related to thromboembolic phenomena (3% of patients with COVID-19 in our cohort), which may not directly affect KL-6 production and eventually spills over into circulation (46).